Clinical Trial Update: Reappraisal of the Therapies of Refractory Autoimmune Hemolytic Anemia in Systemic Lupus Erythematosus [Phase 3]

View source ↗

Summary

Phase 3 clinical trial reappraising therapies for refractory autoimmune hemolytic anemia in systemic lupus erythematosus is in progress, with an unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Hemolytic Anemia
• Systemic Lupus Erythematosus

Snippet

Sponsor: Assiut University | Conditions: Autoimmune Hemolytic Anemia, Systemic Lupus Erythematosus | Phase 3 | Status: UNKNOWN